Once again mjn-neuro has been present at the MWC Barcelona held last February. This time in a different way: we have not had a stand as every year in the 4YFN, but we have been participating in the pitch of healthtech companies.



4YFN is an event of only startups within the MWC at international level that offers the possibility to expose your project showing the best practices in design, implementation and execution to collaborate and create synergies.

David Blánquez, was able to explain firsthand our project: mjn-neuro with all the important points in the development of any startup, sharing practical experience and driving towards success.

Founders, investors and experts share their views and talk about the key factors to take your business to success. Explore the latest trends in culture and entertainment that are leading through technological advancement.

As technology becomes more and more integrated into our lives, this track analyzes and discusses how the latest advances driving innovation are influencing humanity and society, as well as the opportunities and challenges along the way.

On Thursday, part of our team was present to be able to observe, test and analyze the new tools on offer at a technological level within MWC.

The main trends of the MWC as you know are 5G connectivity, advances in AI (artificial intelligence), augmented reality and virtual reality, among others.

Jesús Valls, was sharing with other startups present at 4YFN possible applications that can help us to improve our product. Among them, he was talking with Neuraptic, OXEEN, IDUN and others. The latter was a finalist of the 4YFN Awards.

Some data of MWC Barcelona 2022 in numbers:







attendees from

different countries


4YFN startups

We want to share with you the recent news of mjn-neuro in ABC:


Leave a Reply

Open chat
Contact with us now
Chat with Anna
¡Hola! 👋🏻
Soy Anna, ¿en qué puedo ayudarte?

The user who fills in the information requested in this form declares to be entitled to do so and is solely responsible for the accuracy and completeness of the data and information entered, expressly exonerating MJN NEUROSERVEIS of any liability that may arise for this entity on the occasion of the information provided through this form.

Yes, I accept

L’usuari que complimenta la informació requerida al present formulari declara estar legitimat per això i es fa responsable exclusiu de la veracitat i integritat de les dades i informació que introdueix, exonerant expressament a MJN NEUROSERVEIS de qualsevol responsabilitat que es pugi generar per aquesta entitat amb ocasió de la informació facilitat a través del present formulari.

Si, accepto

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!

    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.


      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.